DR. JAMES OU JIN M.D. NPI 1215900311

NPI Information

  • NPI: 1215900311
  • Provider Name: DR. JAMES OU JIN, M.D.
  • Classification: Internal Medicine - 207RX0202X
  • Specialization: Medical Oncology
  • Entity Type: Individual
  • PECOS Registration: Yes
  • Address: 621 MEMORIAL DR STE 100
    SOUTH BEND, IN
    ZIP 46601
  • Phone: (574) 647-1100

Map and Directions

Get Directions

NPI Details

DR. James Ou Jin, M.D. is a medical oncology internal medicine in South Bend, IN with 43 years of experience. The provider is an internist who specializes in the diagnosis and treatment of all types of cancer and other benign and malignant tumors. This specialist decides on and administers therapy for these malignancies as well as consults with surgeons and radiotherapists on other treatments for cancer. DR. James Ou Jin, M.D. NPI is 1215900311. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

The provider's business location address is:

621 MEMORIAL DR STE 100
SOUTH BEND, IN
ZIP 46601-063
Phone: (574) 647-1100
Fax: (574) 647-3148

The NPI 1215900311 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

  • Injection, ferric carboxymaltose, 1 mg (HCPCS:J1439)
  • Injection, pembrolizumab, 1 mg (HCPCS:J9271)
  • Injection, darbepoetin alfa, 1 microgram (non-esrd use) (HCPCS:J0881)
  • Injection, fosaprepitant, 1 mg (HCPCS:J1453)
  • Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml (HCPCS:Q9967)
  • Injection, denosumab, 1 mg (HCPCS:J0897)
  • Injection, ondansetron hydrochloride, per 1 mg (HCPCS:J2405)
  • Injection, dexamethasone sodium phosphate, 1 mg (HCPCS:J1100)
  • Injection, gadobutrol, 0.1 ml (HCPCS:A9585)
  • Insertion of needle into vein for collection of blood sample (HCPCS:36415)
  • Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
  • Blood test, comprehensive group of blood chemicals (HCPCS:80053)
  • Injection, pegfilgrastim, excludes biosimilar, 0.5 mg (HCPCS:J2506)
  • Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
  • Ferritin (blood protein) level (HCPCS:82728)
  • Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less (HCPCS:96367)
  • Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
  • Cyanocobalamin (vitamin b-12) level (HCPCS:82607)
  • Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
  • Iron level (HCPCS:83540)
  • Transferrin (iron binding protein) level (HCPCS:84466)
  • Lactate dehydrogenase (enzyme) level (HCPCS:83615)
  • Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
  • Injection, diphenhydramine hcl, up to 50 mg (HCPCS:J1200)
  • Injection of drug or substance under skin or into muscle (HCPCS:96372)
  • Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
  • Infusion into a vein for therapy, prevention, or diagnosis, each additional hour (HCPCS:96366)
  • Ct scan of chest with contrast (HCPCS:71260)
  • Administration of additional new drug or substance into vein, 1 hour or less (HCPCS:96417)
  • Application of on-body injector for under skin injection (HCPCS:96377)
  • Blood test, clotting time (HCPCS:85610)
  • Injection, zoledronic acid, 1 mg (HCPCS:J3489)
  • Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries (HCPCS:A9552)
  • Nuclear medicine study from skull base to mid-thigh with ct scan (HCPCS:78815)
  • Ct scan of abdomen and pelvis with contrast (HCPCS:74177)
  • Carcinoembryonic antigen (cea) protein level (HCPCS:82378)
  • Injection of additional new drug or substance into vein (HCPCS:96375)
  • Microscopic examination for white blood cells with manual cell count (HCPCS:85007)
  • Complete blood cell count (red cells, white blood cell, platelets), automated test (HCPCS:85027)
  • New patient office or other outpatient visit, 30-44 minutes (HCPCS:99203)
  • Magnesium level (HCPCS:83735)
  • Red blood count automated, with additional calculations (HCPCS:85046)
  • New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
  • Irrigation of implanted venous access drug delivery device (HCPCS:96523)
  • Initial hospital inpatient care per day, typically 50 minutes (HCPCS:99222)
  • Administration of influenza virus vaccine (HCPCS:G0008)
  • Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) (HCPCS:G0279)
  • Mri scan of brain before and after contrast (HCPCS:70553)
  • Influenza vaccine split virus, preservative free (HCPCS:90662)
  • Follow-up hospital inpatient care per day, typically 25 minutes (HCPCS:99232)
  • Ultrasound study of one arm or leg veins with compression and maneuvers (HCPCS:93971)
  • Ct scan of chest without contrast (HCPCS:71250)
  • Blood test, thyroid stimulating hormone (tsh) (HCPCS:84443)
  • Cardiolipin antibody (tissue antibody) measurement (HCPCS:86147)
  • Diagnostic mammography of both breasts (HCPCS:77066)
  • Blood test, basic group of blood chemicals (calcium, total) (HCPCS:80048)
  • Measurement c-reactive protein for detection of infection or inflammation (HCPCS:86140)
  • Blood creatinine level (HCPCS:82565)
  • Ct scan of soft tissue of neck with contrast (HCPCS:70491)
  • Blood test, lipids (cholesterol and triglycerides) (HCPCS:80061)
  • Ultrasound study of arm or leg veins with compression and maneuvers (HCPCS:93970)

The enumeration date for this NPI number is 2/9/2006 and was last updated on 8/14/2024.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

No. Taxonomy Code Taxonomy Clasification Taxonomy Specialization License Number License State Primary
1207RX0202XInternal MedicineMedical Oncology01061466AINDIANAYes

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.

No. Other Provider Identifier Other Provider Identifier Type Other Provider Identifier State Other Provider Identifier Issuer
1200806670MEDICAIDINDIANA

What is NPI?

NPI stands for National Provider Identifier. The NPI is a 10-digit identification number that is completely unique. The NPI number by itself does not contain any identifiable information such as a provider’s speciality or location. The NPI is assigned to individuals or organizacions for their lifespan and it is independent of key provider information type updates like a change of practices, location or speciality.

This page was last updated on: 11/21/2025

NPI Synchronization or Removal

All materials and services on this site are provided on an "as is" and "as available" basis without warranty of any kind. The NPI record is maintained by the National Plan & Provider Enumeration System (NPPES) and anyone may request this information and other NPPES health care provider data from HHS under The Freedom of Information Act (FOIA), Title 5 of the United States Code, section 552. To update the NPI records please contact the NPPES.